Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-01-24 @ 6:24 AM
Study NCT ID:
NCT04178057
Status:
UNKNOWN
Last Update Posted:
2019-11-27
First Post:
2019-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Sponsor:
Genor Biopharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GENOR GB222-003; V2.1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None